188 related articles for article (PubMed ID: 23555990)
1. Phosphorylated IκBα predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release.
Hussain AR; Uddin S; Ahmed M; Al-Dayel F; Bavi PP; Al-Kuraya KS
PLoS One; 2013; 8(3):e60540. PubMed ID: 23555990
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
[TBL] [Abstract][Full Text] [Related]
3. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.
Sethi G; Ahn KS; Aggarwal BB
Mol Cancer Res; 2008 Jun; 6(6):1059-70. PubMed ID: 18567808
[TBL] [Abstract][Full Text] [Related]
4. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
Bavi P; Uddin S; Bu R; Ahmed M; Abubaker J; Balde V; Qadri Z; Ajarim D; Al-Dayel F; Hussain AR; Al-Kuraya KS
J Pathol; 2011 Jul; 224(3):355-66. PubMed ID: 21506127
[TBL] [Abstract][Full Text] [Related]
5. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis.
Abd-Rabou AA; Abd El-Salam NM; Sharada HMI; Abd El Samea GG; Abdalla MS
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2855-2865. PubMed ID: 34582654
[TBL] [Abstract][Full Text] [Related]
7. The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo.
Lyu MA; Rai D; Ahn KS; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Gandhi V; Rosenblum MG
Neoplasia; 2010 May; 12(5):366-75. PubMed ID: 20454508
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.
Lam LT; Davis RE; Pierce J; Hepperle M; Xu Y; Hottelet M; Nong Y; Wen D; Adams J; Dang L; Staudt LM
Clin Cancer Res; 2005 Jan; 11(1):28-40. PubMed ID: 15671525
[TBL] [Abstract][Full Text] [Related]
9. NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Mason NJ
Clin Cancer Res; 2011 Jul; 17(14):4661-71. PubMed ID: 21610150
[TBL] [Abstract][Full Text] [Related]
10. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.
Dunleavy K; Pittaluga S; Czuczman MS; Dave SS; Wright G; Grant N; Shovlin M; Jaffe ES; Janik JE; Staudt LM; Wilson WH
Blood; 2009 Jun; 113(24):6069-76. PubMed ID: 19380866
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
[TBL] [Abstract][Full Text] [Related]
12. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the IkappaBalpha gene in activated B cell-like diffuse large B-cell lymphoma.
Thomas RK; Wickenhauser C; Tawadros S; Diehl V; Küppers R; Wolf J; Schmitz R
Br J Haematol; 2004 Jul; 126(1):50-4. PubMed ID: 15198731
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Thymoquinone as Anticancer Agent.
Alhmied F; Alammar A; Alsultan B; Alshehri M; Pottoo FH
Comb Chem High Throughput Screen; 2021; 24(10):1644-1653. PubMed ID: 33115388
[TBL] [Abstract][Full Text] [Related]
16. Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines.
Hussain AR; Ahmed M; Al-Jomah NA; Khan AS; Manogaran P; Sultana M; Abubaker J; Platanias LC; Al-Kuraya KS; Uddin S
Mol Cancer Ther; 2008 Oct; 7(10):3318-29. PubMed ID: 18852135
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis.
Chen S; Fu L; Raja SM; Yue P; Khuri FR; Sun SY
Mol Cancer; 2010 Jan; 9():23. PubMed ID: 20113484
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.
Hussain AR; Uddin S; Bu R; Khan OS; Ahmed SO; Ahmed M; Al-Kuraya KS
PLoS One; 2011; 6(9):e24703. PubMed ID: 21931821
[TBL] [Abstract][Full Text] [Related]
19. Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells.
Wu W; Yang Y; Deng G; Ma L; Wei G; Zheng G; Han X; He D; Zhao Y; He J; Cai Z; Yu R
Mol Carcinog; 2017 Oct; 56(10):2190-2199. PubMed ID: 28467689
[TBL] [Abstract][Full Text] [Related]
20. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
Deeb D; Jiang H; Gao X; Hafner MS; Wong H; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
Mol Cancer Ther; 2004 Jul; 3(7):803-12. PubMed ID: 15252141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]